Farokem 200 CV Tablet is a potent antibiotic formulation combining Faropenem (200mg) and Clavulanic Acid (125mg) designed to combat a broad spectrum of bacterial infections. Faropenem, a beta-lactam antibiotic belonging to the penem class, exhibits strong bactericidal activity by inhibiting bacterial cell wall synthesis, effectively targeting both Gram-positive and Gram-negative bacteria. Clavulanic Acid acts as a beta-lactamase inhibitor, preventing the enzymatic degradation of Faropenem by resistant bacterial strains, thereby enhancing its efficacy. This combination is particularly useful in treating respiratory tract infections, urinary tract infections, skin and soft tissue infections, and other bacterial infections where resistance to standard antibiotics is a concern. Farokem 200 CV is typically prescribed based on the severity and type of infection and should be used under medical supervision to ensure appropriate dosing and duration. Patients are advised to complete the full course of therapy to prevent resistance development. Common side effects may include gastrointestinal disturbances such as nausea, diarrhea, and abdominal discomfort. Caution is advised in patients with a history of penicillin allergy or hypersensitivity to beta-lactam antibiotics. Overall, Farokem 200 CV Tablet offers an effective therapeutic option for managing resistant bacterial infections with improved clinical outcomes.